AU2658092A - A method of screening for inhibitors of heparin-binding protein - Google Patents

A method of screening for inhibitors of heparin-binding protein

Info

Publication number
AU2658092A
AU2658092A AU26580/92A AU2658092A AU2658092A AU 2658092 A AU2658092 A AU 2658092A AU 26580/92 A AU26580/92 A AU 26580/92A AU 2658092 A AU2658092 A AU 2658092A AU 2658092 A AU2658092 A AU 2658092A
Authority
AU
Australia
Prior art keywords
heparin
inhibitors
screening
binding protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26580/92A
Inventor
Hans Flodgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2658092A publication Critical patent/AU2658092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU26580/92A 1991-09-12 1992-09-09 A method of screening for inhibitors of heparin-binding protein Abandoned AU2658092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK9100264 1991-09-12
WODK9100264 1991-09-12

Publications (1)

Publication Number Publication Date
AU2658092A true AU2658092A (en) 1993-04-05

Family

ID=8153694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26580/92A Abandoned AU2658092A (en) 1991-09-12 1992-09-09 A method of screening for inhibitors of heparin-binding protein

Country Status (4)

Country Link
EP (1) EP0645016A1 (en)
JP (1) JPH07504081A (en)
AU (1) AU2658092A (en)
WO (1) WO1993005396A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2127230A1 (en) * 1993-07-01 1995-01-02 Louis G. Lange, Iii Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase
GB9514368D0 (en) * 1995-07-13 1995-09-13 Medical Res Council Improvements in or relating to binding assays
CA2324424A1 (en) 1998-03-26 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Method for searching steroid sulfatase inhibitors
ATE312622T1 (en) * 1999-04-29 2005-12-15 Novo Nordisk As USE OF ANTI-HBP ANTIBODIES TO INHIBIT BRADYKININ RELEASE
EP1674110A1 (en) * 1999-04-29 2006-06-28 Novo Nordisk A/S Inhibition of bradykinin release
IL153762A0 (en) * 2002-12-31 2003-07-06 Rimonyx Pharmaceuticals Ltd Methods of screening for anti-inflammatory drugs and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68911297T2 (en) * 1988-03-17 1994-03-31 Novo Nordisk As HEPARIN-BINDING PROTEINS, CODING DNA, METHOD FOR THE PRODUCTION THEREOF AND THE THERAPEUTIC PREPARATIONS CONTAINING THEM.

Also Published As

Publication number Publication date
EP0645016A1 (en) 1995-03-29
WO1993005396A1 (en) 1993-03-18
JPH07504081A (en) 1995-05-11

Similar Documents

Publication Publication Date Title
AU5324996A (en) Protein kinase c inhibitors
AU4844593A (en) Specification method and apparatus for peptide synthesis and screening
NZ323571A (en) Protein kinase c inhibitor
AU5332196A (en) Method for protein folding
AU1928292A (en) 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymatic glycosylation of proteins
GB2304226B (en) Method for discriminating a type of disk
AU6208490A (en) Screening methods for protease inhibitors
AU4783293A (en) Method for screening compositions
AU1291097A (en) A novel protein kinase required for ras signal transduction
AU7658594A (en) Method for repeating of a sound
GB9114734D0 (en) Process for modifying proteins
AU2658092A (en) A method of screening for inhibitors of heparin-binding protein
EP0831878A4 (en) Novel peptide inhibitors of calmodulin
GB2300545B (en) A method for processing signals
AU1117995A (en) Method for acylation of starch
AU1180195A (en) Method of identifying a substance capable of inducing bone formation
AU5440596A (en) Inhibiting degradation of a degron-bearing protein
AU2563192A (en) A method of manufacturing a screening drum
AU7338294A (en) Method for endomodification of proteins
AU1882492A (en) A method for the manufacture of chemithermomechanical pulp
AU3895293A (en) Method of testing for salmonella
AU3088392A (en) Method for determination of inductance
AU1422697A (en) Method for harvesting a protein
AU2377392A (en) A method for the identification of protease inhibitors
AU6670894A (en) Method for preparing a metal-radionuclide-labelled protein